Novartis

Rilzabrutinib significantly reduces itch and hives in patients with chronic spontaneous urticaria unresponsive to antihistamines, in a phase 2 study.

The Swiss pharma giant plans to expand existing facilities and build three new manufacturing plants

This is the first update to evidence-based recommendations for managing familial Mediterranean fever in more than 8 years.

It's unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.

But long-term trial data still needed to support traditional approval

Korean randomized trial shows hard endpoint benefit without a difference in bleeding

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established atherosclerotic disease, CKD, or both.

/PRNewswire-PRWeb/ -- Women We Admire is pleased to announce The Rising Star Women Leaders in Medicine for 2025. Medicine is a constantly evolving field that...

Why Google DeepMind, Perplexity, Khan Academy, Canva, and Salesforce are among Fast Company's Most Innovative Companies for 2025.

A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some patients with NSCLC but do not impact survival.

MS presentations vary at the ends of the age spectrum

In men with PSA persistence, higher pre-op PSA tied to lower mortality, suggesting overtreatment

Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.

Yes, study suggests, but results may not represent a meaningful impact, expert says

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped treatment stayed clear or nearly clear for 8 weeks.

New research testing the newly proposed McDonald Criteria showed that they boost diagnostic yield.

Post-treatment, most kids on omalizumab tolerated allergenic foods

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ulcerative colitis as well as in those with Crohn's disease.

Findings suggest possible benefits of ICI therapy on field cancerization, researchers say

Prenatal and early life sun exposure is associated with a lower risk for relapse in childhood-onset MS, new findings suggest, but investigators say more research is needed.